Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a multicenter, interventional, randomized study for preventive and therapeutic strategies for patients with head and neck or Lung cancer; contribution of an addiction support
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Group A | Experimental |
| |
| Group B | No Intervention |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Addiction support | Other | one consultation with an addiction specialist |
|
| Measure | Description | Time Frame |
|---|---|---|
| systematic addiction consultation | difference between abstinence in group A and abstinence in group B | 12 months after diagnosis |
| Measure | Description | Time Frame |
|---|---|---|
| progression free survival | median time between date of inclusion and date of first progression | 24 months after diagnosis |
| overall survival | median time between date of inclusion and date of death |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Corinne VANNIMENUS, MD | Centre Hospitalier Régional et Universitaire | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Oscar Lambret Center | Lille | 59 020 | France | |||
| Centre Hospitalier Régional et Universitaire - Hopital CALMETTE |
Not provided
| ID | Term |
|---|---|
| D006258 | Head and Neck Neoplasms |
| D008175 | Lung Neoplasms |
| ID | Term |
|---|---|
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D012142 | Respiratory Tract Neoplasms |
| D013899 | Thoracic Neoplasms |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 24 months after survival |
| alcohol and tobacco consumption | frequency of tobacco and alcohol consumption questionnaire : Fagerström, Alcohol Use Disorders Identification Test (AUDIT), Cut Down Annoyed Guilty Eye-Opener (CAGE-DETA), Cannabis abuse screening test (CAST), M.I.N.I. | baseline, 3 months, 6 months and 12 months after diagnosis |
| alcohol + tobacco withdrawal and addiction support | difference between abstinence of group A and abstinence group B | 12 months after diagnosis |
| addiction follow up | percentage of patient with a first addiction consultation, and willing to have a long term follow up | 24 months after diagnosis |
| Lille |
| 59 037 |
| France |
| Centre Hospitalier Régional et Universitaire - Hopital HURIEZ | Lille | 59 037 | France |
| D008171 |
| Lung Diseases |
| D012140 | Respiratory Tract Diseases |